The GPR30 receptor agonist G1 inhibits ferroptosis and significantly improves chondrocyte viability and motor ability in mice through the YAP1/FTH1 pathway, while GPR30 receptor antagonist G15 has the opposite effect, suggesting that hormone-related ferroptosis may emerge as a promising target for alleviating osteoarthritis in postmenopausal women
Combining genetic predisposition data with your bariatric historyprocedure type, time since surgery, weight-loss plateau, and lab resultscan deepen your provider's understanding of why a particular GLP-1 approach may work better for you
New England Journal of Medicine, 337(9), 581-588
Most patients experience peak nausea during the first 2-3 weeks, with symptoms declining substantially as their body adjusts to the new metabolic signals
Being aware of these possibilities allows you to monitor your body and report any concerns right away